|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | (2013.01) |
| A61K 31/485 | (2006.01) | ||
| A61K 31/593 | (2006.01) | ||
| A61K 31/485 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/593 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/55511 | (2013.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61K 39/39 | (2013.01) | ||
| C07D 489/08 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 2994137 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14725506.1 |
| Date of filing the European patent application | 2014-05-12 | |
| (97) | Date of publication of the European application | 2016-03-16 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2014/051439 |
| Date | 2014-05-12 |
| (87) | Number | WO 2014/181131 |
| Date | 2014-11-13 |
| (30) | Number | Date | Country code |
| 201308440 | 2013-05-10 | GB |
| (72) |
DALGLEISH, Angus , GB
ALLEN, Rachel , GB
|
| (73) |
LDN Pharma Limited ,
45 Gresham Street, London EC2V 7BG,
GB
|
| (54) | TREATMENT OF CANCER WITH NALTREXONE |
| TREATMENT OF CANCER WITH NALTREXONE |